The treatment paradigm for RA has changed significantly with the advent of biologic therapies, including inhibitors of TNF-α, costimulation blockade, CD20-mediated B cell depletion and modulation of the IL-6 pathway [35]. This evidence concerns the gene TNF and rheumatoid arthritis.